Understanding and Managing Pregnancy in Patients with Lupus.

Area of Science:

• Rheumatology
• Obstetrics
• Immunology

Background:

• Systemic lupus erythematosus (SLE) predominantly affects women of reproductive age.
• SLE during pregnancy, particularly with active disease or nephritis, is linked to adverse outcomes like preeclampsia, fetal loss, and growth restriction.
• Pregnancy involves significant immune and neuroendocrine shifts that can be impacted by SLE.

Purpose of the Study:

• To highlight the high-risk nature of SLE pregnancies.
• To emphasize the importance of frequent monitoring and controlled delivery settings.
• To discuss factors influencing SLE flares during pregnancy and diagnostic challenges.

Main Methods:

• Review of existing literature on SLE and pregnancy outcomes.
• Discussion of maternal immune and neuroendocrine changes during pregnancy in SLE patients.
• Exploration of diagnostic tools, including angiogenic/antiangiogenic cytokines, for differentiating lupus nephritis and preeclampsia.

Main Results:

• SLE pregnancies are associated with increased rates of preeclampsia, fetal loss, prematurity, and small for gestational age newborns.
• Maternal disease activity prior to conception, especially active glomerulonephritis, increases the risk of flares.
• Differentiating lupus nephritis from preeclampsia is challenging, with cytokines showing promise.

Conclusions:

• SLE pregnancies require intensive monitoring and collaborative care between rheumatologists and obstetricians.
• Pregnancy planning is essential for improving outcomes in women with SLE.
• Controlled delivery settings are recommended for SLE patients.